Skip to search.
 TSX Up 0.16% TSX Ventures Down 0.30%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
53.30 Down 2.03(3.67%) 4:00PM EDT
|After Hours : 53.29 Down 0.01 (0.02%) 4:00PM EDT - Nasdaq Real Time Price
Prev Close:55.33
Open:55.32
Bid:53.30 x 100
Ask:53.57 x 100
1y Target Est:51.71
Beta:1.9782
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:53.03 - 55.51
52wk Range:26.02 - 57.23
Volume:879,856
Avg Vol (3m):762,891
Market Cap:7.49B
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENDown 3.67%7.49B
IMGNDown 3.99%231.41M
PFEDown 1.97%202.11B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.00
Quarterly EPS Est (Sep-16) :-0.29
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-3.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback